Medicare Enrolled
Dr. Muhammad Saad Khan, M.D.
Hematology & Oncology · Champaign, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Khan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khan
Dr. Muhammad Saad Khan is a hematology & oncology specialist in Champaign, IL, with 14 years of NPI registration. Based on federal Medicare data, Dr. Khan performed 137,379 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Khan received a total of $3,363 from 39 pharmaceutical and/or device companies across 145 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years of NPI registration
▲ Top 9% volume in IL
$3,363 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗137,379
Medicare services
Top 9% in IL for hematology & oncology
Not available
Unique patients (not deduplicated)
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
35,800 | $0 | $1 |
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
25,500 | $1 | $3 |
| Pembrolizumab injection (Keytruda) | 17,400 | $43 | $103 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
17,100 | $2 | $7 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
15,810 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 9,600 | $18 | $42 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
6,750 | $0 | $4 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,810 | $0 | $1 |
| Anti-nausea injection (ondansetron/Zofran) | 1,585 | $0 | $2 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
853 | $95 | $397 |
| Anti-nausea injection (Aloxi/palonosetron) | 560 | $1 | $32 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
534 | $1 | $2 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
406 | $11 | $48 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
404 | $13 | $61 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
384 | $93 | $455 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
367 | $111 | $526 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
231 | $2 | $41 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
202 | $8 | $26 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
198 | $54 | $261 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
198 | $6 | $72 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
193 | $10 | $36 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
181 | $11 | $49 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
165 | $135 | $553 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
141 | $30 | $145 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
106 | $27 | $127 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
104 | $20 | $103 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
103 | $119 | $518 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
89 | $54 | $254 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
84 | $17 | $77 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
78 | $24 | $113 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
69 | $1 | $2 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
62 | $24 | $110 |
| New patient office visit, complex (60-74 min) | 52 | $159 | $669 |
| Injection, alteplase recombinant, 1 mg | 51 | $66 | $175 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
48 | $62 | $271 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
39 | $27 | $115 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
36 | $1 | $4 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
31 | $1 | $4 |
| Central venous tube declotting A procedure to clear a blockage or clot from a central venous catheter to restore its function. |
26 | $28 | $120 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
15 | $8 | $29 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
14 | $147 | $652 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
30.7% high complexity
67.8% medium
1.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,363
Total received (2018-2024)
Avg $480/year across 7 years
Top 49% in IL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
145
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$829
2023
$593
2022
$299
2021
$13
2020
$171
2019
$786
2018
$671
Payments by company (2024)
Janssen Biotech, Inc.
$134
Novartis Pharmaceuticals Corporation
$132
AstraZeneca Pharmaceuticals LP
$87
Tempus AI, Inc
$78
Merck Sharp & Dohme LLC
$60
Gilead Sciences, Inc.
$56
Genentech USA, Inc.
$51
PFIZER INC.
$51
E.R. Squibb & Sons, L.L.C.
$47
Exelixis Inc.
$39
Daiichi Sankyo Inc.
$29
Incyte Corporation
$25
Ipsen Biopharmaceuticals, Inc
$24
Alnylam Pharmaceuticals Inc.
$16
Top 3 companies account for 42.7% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$391
Novartis Pharmaceuticals Corporation
$278
Astellas Pharma US Inc
$248
PFIZER INC.
$204
Amgen Inc.
$192
Genentech USA, Inc.
$155
Janssen Biotech, Inc.
$153
AstraZeneca Pharmaceuticals LP
$137
Seagen Inc.
$124
Daiichi Sankyo Inc.
$114
TESARO, Inc.
$114
Merck Sharp & Dohme LLC
$106
Incyte Corporation
$99
Eisai Inc.
$85
Celgene Corporation
$79
Gilead Sciences, Inc.
$79
Tempus AI, Inc
$78
Merck Sharp & Dohme Corporation
$74
PharmaEssentia USA Corporation
$72
Bayer HealthCare Pharmaceuticals Inc.
$66
Boehringer Ingelheim Pharmaceuticals, Inc.
$53
Exelixis Inc.
$39
Mirati Therapeutics, Inc.
$37
Alnylam Pharmaceuticals Inc.
$35
Alexion Pharmaceuticals, Inc.
$32
Takeda Pharmaceuticals U.S.A., Inc.
$32
TAIHO ONCOLOGY, INC.
$31
Agios Pharmaceuticals, Inc.
$28
MorphoSys, US Inc.
$25
Ipsen Biopharmaceuticals, Inc
$24
EISAI INC.
$24
GENZYME CORPORATION
$23
ImmunoGen, Inc.
$23
Taiho Oncology, Inc.
$20
AMAG Pharmaceuticals, Inc.
$20
Puma Biotechnology, Inc.
$19
Rigel Pharmaceuticals, Inc.
$19
Janssen Pharmaceuticals, Inc
$18
EMD Serono, Inc.
$12
Top 3 companies account for 27.3% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · Aliqopa · Avastin · BESREMI · BOSULIF · Bavencio · CABOMETYX · CALQUENCE · CRESEMBA · Columvi · ELIQUIS · ELITEK · EMEND · Elahere · Enhertu · FERAHEME · Fabhalta · GAZYVA · GILOTRIF · GIVLAARI · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LONSURF · Lenvima · MONJUVI · NERLYNX · Nexavar · OPDIVO · OPDUALAG · OXBRYTA · Onivyde · PADCEV · PLUVICTO · PROMACTA · Perjeta · Pomalyst · Prolia · RYBREVANT · Revlimid · SANDOSTATIN LAR · SCEMBLIX · TABRECTA · TAGRISSO · TIBSOVO · TIVDAK · Tavalisse · ULTOMIRIS · VOTRIENT · XALKORI · XARELTO · XGEVA · XOSPATA · XT CDX · XTANDI · ZEJULA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
13
County median income
$63,091
Nearest hospital to ZIP centroid (approximate)
THE PAVILION
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Khan is a mixed practice specialist, with above-average Medicare volume (top 9% in IL).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Khan experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Khan performed 35,800 iron sucrose injection (venofer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Khan receive payments from pharmaceutical companies?
Yes. Dr. Khan received a total of $3,363 from 39 companies across 145 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khan's costs compare to other hematology & oncology specialists in Champaign?
Dr. Khan's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Champaign
Browse hematology & oncology specialists in Champaign ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in IL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in IL
Which IL hematology & oncology specialists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology